Bank of America’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183M Buy
546,930
+12,326
+2% +$3.9M 0.01% 825
2026
Q1
$172M Buy
534,604
+11,841
+2% +$3.66M 0.01% 806
2025
Q4
$154M Buy
522,763
+39,902
+8% +$7.43M 0.01% 862
2025
Q3
$25.6M Buy
482,861
+29,458
+6% +$1.43M ﹤0.01% 2372
2025
Q2
$19.1M Sell
453,403
-7,304
-2% -$278K ﹤0.01% 2600
2025
Q1
$17.4M Buy
460,707
+455,203
+8,270% +$28.4M ﹤0.01% 2589
2024
Q4
$424K Sell
5,504
-44,345
-89% -$3.21M ﹤0.01% 5671
2024
Q3
$2.87M Buy
49,849
+11,295
+29% +$610K ﹤0.01% 4247
2024
Q2
$1.59M Buy
38,554
+19,550
+103% +$924K ﹤0.01% 4595
2024
Q1
$1.16M Sell
19,004
-259,858
-93% -$11.7M ﹤0.01% 4839
2023
Q4
$6.21M Buy
278,862
+788
+0.3% +$14.2K ﹤0.01% 3367
2023
Q3
$7.13M Sell
278,074
-18,738
-6% -$355K ﹤0.01% 3065
2023
Q2
$5.12M Buy
296,812
+28,427
+11% +$435K ﹤0.01% 3382
2023
Q1
$3.26M Buy
268,385
+167,390
+166% +$7.07M ﹤0.01% 3933
2022
Q4
$3.61M Buy
100,995
+98,762
+4,423% +$3.08M ﹤0.01% 3715
2022
Q3
$76K Sell
2,233
-18,569
-89% -$925K ﹤0.01% 6486
2022
Q2
$764K Buy
20,802
+13,683
+192% +$1.46M ﹤0.01% 5132
2022
Q1
$1.09M Buy
7,119
+963
+16% +$198K ﹤0.01% 5147
2021
Q4
$1.82M Buy
6,156
+4,488
+269% +$1.32M ﹤0.01% 4658
2021
Q3
$462K Buy
1,668
+717
+75% +$195K ﹤0.01% 5717
2021
Q2
$262K Buy
951
+120
+14% +$43K ﹤0.01% 5902
2021
Q1
$409K Buy
831
+661
+389% +$470K ﹤0.01% 5525
2020
Q4
$141K Buy
+170
New +$99.2K ﹤0.01% 5816

Other funds holding PRAX

Bank of America's PRAX Position: Q2 2026 in Review

Bank of America increased its Praxis Precision Medicines (PRAX) stake by 2.3% in Q2 2026, buying an estimated $3.9M and bringing the position to 546,930 shares worth $183M. The position accounts for 0.01% of the portfolio, ranked #825.

Bank of America first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bank of America held 546,930 shares of Praxis Precision Medicines worth $183M as of Q2 2026.
  • Bank of America bought 12,326 Praxis Precision Medicines shares in Q2 2026, an estimated $3.9M.
  • Praxis Precision Medicines made up 0.01% of Bank of America's portfolio in Q2 2026, its #825 holding.
  • Bank of America first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.